Please select an option below to help us tailor your newsletter to best suit your content interests!
Advancing Cancer Care from the United States to Uzbekistan Just 30 years ago, nearly 27% of hospitals in the country of Uzbekistan didn’t have sewage systems and 17% didn’t even have access to running water. Since the country’s independencefrom Russia in 1991, Uzbekistan has made drastic improvements to its healthcare system to better serve its… Read more »
Wendy Brotherton, Data Scientist, here at West shares insight in digital transformation in healthcare. Our objective is to develop data environments that will help our clinical processes, patient satisfaction, and real-time data sharing for physicians. Click the link to watch the full presentation. https://www.youtube.com/watch?v=H2H23K2I_88
One of our incredible breast medical oncologists, Dr. Gregory Vidal, spearheaded the coordination of Ciara Lee’s long distance journey from Dominica here to Memphis for life-saving brain surgery by Dr. Klimo at Semmes Murphey Clinic, PC! We are so proud of our compassionate providers that go above and beyond to promote health & wellness for our… Read more »
Dr. Jason Porter talks with OncLive about potential sequencing with antibody-drug conjugates (ADCs) and tyrosine kinase inhibitors (TKIs) for HER2+ #lungcancer. Porter states, “The TKIs are oral medications that target HER2 specifically and do not require intravenous infusion. Given the ongoing COVID-19 pandemic, the utility of outpatient therapy with the TKIs may be preferrable to trastuzumab deruxtecan. However,… Read more »
Portnoy says, “It’s been a long time since we’ve had a breakthrough in small cell lung cancer (#SCLC), and we are finally seeing some real concrete improvements in survival with first-line therapy and with those who have progressed on first line therapy. After years of heartbreak and minimal improvement, we’re beginning to see these breakthroughs… Read more »
Dr. Axel Grothey talks with Targeted Oncology how #HER2 has become an actionable target for #GIcancers and potential HER2-targeted treatments in the field, as well as other interesting studies from the role trastuzumab plays in the GI cancer clinical space. Click to read a transcript of this full interview!
Dr. Jason Porter, one of our incredible Lung Oncology Specialists, recently participated in an OncLive “Institutional Perspectives in Cancer” webinars, which allows attendees to consume and digest data easily and take what they learned back to their clinical practice. Click here to watch the full panel webinar with Jason Porter, MD, Janakiraman Subramanian, MD, Natalie S. Calendar,… Read more »
Our very own, Dr. Noam VanderWalde, participated in the third edition of tipsRo’s new webinar series “Ask the Authors.” Dr. VanderWalde and Dr. Niluja Thiruthaneeswaran, Radiation Oncologist at Crown Princess Mary Cancer Centre In Austrailia, hosted this webinar specifically focused on Geriatric Oncology in Radiotherapy. Click here to review the resources and downloads available from… Read more »
“The management of locally advanced #RectalCancer has grown in both complexity and quality since the first proctectomy. What once was a malignancy with a fairly consistent treatment algorithm for decades, a recent paradigm shift in the care of these patients has led to a more personalized, multidisciplinary approach with variations in timing, sequence, duration, and potential exclusion… Read more »
Axel Grothey, MD, medical oncologist and director of Gastrointestinal Cancer Research at West Cancer Center and Research Institute, discusses the potential utility of trifluridine/tipiracil (TAS-102; Lonsurf) in combination with bevacizumab (Avastin) in metastatic colorectal cancer (mCRC). Currently, TAS-102 is reserved for single-agent use in the third-line setting for patients with mCRC, says Grothey. However, TAS-102… Read more »